November is Lung Cancer Awareness month, and lung cancer is currently the leading cause of cancer-related death in men and women.
A new FDA-approved blood test is givings lung cancer patients and their treating oncologists critical information about the biomarkers in their cancer to help inform more effective, personalized and targeted treatment options.
For advanced cancer patients, every day is precious and crucial from a treatment perspective. Waiting weeks for results from a tissue biopsy, which usually requires surgery, can delay treatment or result in a patient being put on treatment before the result is received. These new blood tests represent hope for patients with advanced lung cancer who are eager to begin the most appropriate treatment.
Learn more here.